Theresa LaVallee
Chief Development Officer
Other
Earnings-call appearances
-
Q2 2026 Coherus Oncology, Inc. Earnings Conference Call2026-08-05
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q3 FY2025 Earnings Call2025-11-06
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q2 FY2025 Earnings Call2025-08-07
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q1 FY2025 Earnings Call2025-05-12
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q4 FY2024 Earnings Call2025-03-10
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q3 FY2024 Earnings Call2024-11-06
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q1 FY2024 Earnings Call2024-05-09
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q4 FY2023 Earnings Call2024-03-13
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q3 FY2023 Earnings Call2023-11-06
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q2 FY2023 Earnings Call2023-08-02
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q1 FY2023 Earnings Call2023-05-08
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q4 FY2022 Earnings Call2023-03-06
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q3 FY2022 Earnings Call2022-11-08
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q1 FY2022 Earnings Call2022-05-05
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q4 FY2021 Earnings Call2022-02-17
Coherus Oncology, Inc. (CHRS)